These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3369092)

  • 21. Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus.
    Balzarini J; Kruining J; Wedgwood O; Pannecouque C; Aquaro S; Perno CF; Naesens L; Witvrouw M; Heijtink R; De Clercq E; McGuigan C
    FEBS Lett; 1997 Jun; 410(2-3):324-8. PubMed ID: 9237655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
    Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1080-6. PubMed ID: 3649230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro.
    Hirabayashi K; Iwata S; Ito M; Shigeta S; Narui T; Mori T; Shibata S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2410-2. PubMed ID: 2575016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.
    Tochikura TS; Nakashima H; Ohashi Y; Yamamoto N
    Med Microbiol Immunol; 1988; 177(5):235-44. PubMed ID: 3173237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
    Baba M; Pauwels R; Herdewijn P; De Clercq E; Desmyter J; Vandeputte M
    Biochem Biophys Res Commun; 1987 Jan; 142(1):128-34. PubMed ID: 3028398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
    Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
    Haraguchi Y; Takeuchi Y; Hoshino H
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains.
    Dolei A; Serra C; Arca MV; Tilocca F; Riva E; Antonelli G; Dianzani F; Toniolo A
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1089-95. PubMed ID: 7826696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania.
    Easterbrook MD; Levy MH; Gomez AM; Turco SJ; Epand RM; Rosenthal KL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):496-505. PubMed ID: 8548328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
    Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
    Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3'-azido-2',3'-dideoxythymidine.
    Perigaud C; Aubertin AM; Benzaria S; Pelicano H; Girardet JL; Maury G; Gosselin G; Kirn A; Imbach JL
    Biochem Pharmacol; 1994 Jul; 48(1):11-14. PubMed ID: 8043011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.
    Ankel H; Turriziani O; Antonelli G
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2797-800. PubMed ID: 1940869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
    Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy of human immunodeficiency virus-related disease.
    Mitsuya H; Yarchoan R; Kageyama S; Broder S
    FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIVHTLV-IIIB cells.
    Matsuyama T; Hamamoto Y; Yoshida T; Kido Y; Kobayashi S; Kobayashi N; Yamamoto N
    Jpn J Cancer Res; 1988 Feb; 79(2):156-9. PubMed ID: 3130348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus.
    Mizuno T; Uchino K; Toukairin T; Tanabe A; Nakashima H; Yamamoto N; Ogawara H
    Planta Med; 1992 Dec; 58(6):535-9. PubMed ID: 1484893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.
    Walker BD; Kowalski M; Goh WC; Kozarsky K; Krieger M; Rosen C; Rohrschneider L; Haseltine WA; Sodroski J
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8120-4. PubMed ID: 2825177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
    Mohan P; Singh R; Baba M
    Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.